Subclinical Changes in Type 2 Diabetes Patients with Heart Failure Stage A and B Treated with Oral Semaglutide

Subclinical Changes in Type 2 Diabetes Patients with Heart Failure Stage A and B Treated with Oral Semaglutide

<i>Background and Objectives</i>: Heart failure (HF) among patients with type 2 diabetes (T2DM) is linked to significant morbidity and mortality, despite the increased availability of new drug therapy. This study aims to investigate subclinical changes in patients with HF stage A (at ris...

Full description

Saved in:
Bibliographic Details
Main Authors: Larissa Dăniluc, Adina Braha, Oana Elena Sandu, Carina Bogdan, Loredana Suhov, Lina Haj Ali, Alexandra-Iulia Lazăr-Höcher, Alexandra Sima, Adrian Apostol, Mihaela Viviana Ivan
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Medicina
Subjects:
speckle-tracking echocardiography
GLP-1 receptor agonists
visceral adiposity
metabolic control
Online Access:https://www.mdpi.com/1648-9144/61/4/567
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1648-9144/61/4/567

Similar Items